QUIBIM awarded with Phase I of SME Instrument Program 2016 H2020 by the European Commission  


QUIBIM is one of the disruptive companies selected by the EU to be granted with the first round of Horizon 2020 SME Instrument Phase I Program 2016 under the call: “SMEInst-01-2016-2017: Open Disruptive Innovation Scheme”. A H2020 funding-call with a success rate of 10%.

The dedicated SME instrument supports close-to-market activities, with the aim to give a strong boost to breakthrough innovation. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalization are the prime target.

The European Commission will support QUIBIM project either economically and with a coaching program, helping it grow and expand as an international core reference laboratory for image centralization and medical image processing.

QUIBIM team is really proud of being elected by the EU with its first submitted proposal and we are really grateful for this relevant acknowledgment. We are already working on phase I, exploring and assessing the commercial potential of our innovative medical imaging services.

QUIBIM ha sido seleccionada por la Comisión Europea para la Fase I del Programa Instrumento PYME 2016 del H2020

QUIBIM ha sido una de las empresas seleccionadas por la CE en la primera convocatoria de Fase I del Programa Instrumento PYME 2016 del H2020 bajo la llamada: “SMEInst-01-2016-2017: Open Disruptive Innovation Scheme”. Un Programa del H2020 con una tasa de éxito del 10%.

El Instrumento PYME es una inicitativa dedicada al apoyo de actividades cercanas a mercado con el objetivo de impulsar la innovación disruptiva. PYMEs altamente innovadoras, con una ambición comercial clara y alto potencial de crecimiento e internacionalización son las candidatas a ser subvencionadas por este Programa.

La Comisión Europea apoyará el proyecto QUIBIM tanto económicamente como con ‘coaching’ internacional, impulsando así el crecimiento y la expansion de la empresa como laboratorio internacional de referencia para la centralización y el procesamiento de imágenes médicas.

En el equipo QUIBIM estamos muy orgullosos de haber sido elegidos por la CE en nuestra primera propuesta presentada y agradecidos por este importante reconocimiento. Actualmente, nos encontramos ya trabajando en esta Fase I, inmersos en la exploración y la evaluación del potencial comercial de nuestros servicios disruptivos en imagen médica.


Angel Alberich-Bayarri

Telecommunications & Electronics Engineer by the Polytechnics University of Valencia. Master in Biomedical Engineering and PhD achieved in 2010 by the Polytechnics University of Valencia, due to his research in the application of advanced image processing techniques to high spatial resolution Magnetic Resonance images for the study of bone structure. In the professional aspect, he is scientific-technical director of the Biomedical Imaging Research Group at La Fe Polytechnics and University Hospital and an entrepreneur and co-founder of QUIBIM (Quantitative Imaging Biomarkers in Medicine) company. He previously served as Director of Biomedical Engineering (2012-2014) and R&D engineer (2007-2012) in Quiron Hospital Group. He is the inventor of two patents in the field of medical imaging. He is also the author of over 25 scientific articles, 60 communications to international congresses and 10 book chapters. He has participated in a number of research projects and clinical trials. He is an active member of several scientific societies, among which the European Society of Medical Imaging Informatics (EUSOMII) being a member of the Board. He is also a member of the eHealth and Informatics subcommittee of the European Society of Radiology. In the educational area, he is collaborator of the Polytechnics University of Valencia in the supervision of final projects, theses and PhD’s and of the Faculty of Medicine at the University of Valencia as lecturer at Advanced Medical Imaging. In 2012 he was awarded by the Polytechnic University of Valencia with the Best PhD in the field of ICT’s and by the European Society of Radiology with the Best Scientific Paper Award for its advances in the application of engineering to the study of cardiovascular remodelling. In 2013 he received the Pro-European Academy Prize award, given to leading scientists exemplary groups in science and academic life. In 2014 he was recognized by the European Society of Radiology with the award for the best scientific contribution in the field of oncology. In November 2015 he was awarded by the Massachusetts Institute of Technology (MIT) official publication MIT Technology Review, with the award "MIT Innovators Under 35".

All stories by: Angel Alberich-Bayarri

Leave a Reply

Your email address will not be published.